| Literature DB >> 26622842 |
Feifei Pu1, Zengwu Shao1, Shuhua Yang1, Jianxiang Liu1, Song Lin1, Xiucai Ma1, Haofei Yang1.
Abstract
Baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5)/survivin genetic microRNA (miRNA) binding site variants in the 3' untranslated region (3'UTR) are known to be significantly associated with cancer risk. However, the roles of genetic variants in BIRC5/survivin gene 3'UTRs and post-transcriptional regulation have not been elucidated. In the present study, we revealed that rs1042489, rs1042542, rs17882360, rs2239680, rs2661694 and rs4789560 in the BIRC5/survivin 3'UTR have potential miRNA binding sites using bioinformatics analysis. However, only rs1042489 was significantly associated with BIRC5/survivin mRNA expression in lymphoblastoid cell lines (P=0.030); rs1042489 may be a putative variant mediating the post-transcriptional regulation of the target BIRC5/survivin gene. An in-depth understanding of how 3'UTR variants regulate BIRC5/survivin activity is expected to pave the way to targeting the BIRC5/survivin pathway in cancer therapy.Entities:
Keywords: baculoviral inhibitor of apoptosis repeat-containing 5; genetic; microRNA; polymorphisms; survivin; variant
Year: 2015 PMID: 26622842 PMCID: PMC4579978 DOI: 10.3892/ol.2015.3507
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967